A Chemical Genetic Approach for Covalent Inhibition of Analogue-Sensitive Aurora Kinase
- 1 February 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 7 (4) , 723-731
Abstract
The perturbation of protein kinases with small organic molecules is a powerful approach to dissect kinase function in complex biological systems. Covalent kinase inhibitors that target thiols in the ATP binding pocket of the kinase domain proved to be ideal reagents for the investigation of highly dynamic cellular processes. However, due to the covalent inhibitors' possible off-target reactivities, it is required that the overall shape of the inhibitor as well as the intrinsic reactivity of the electrophile are precisely tuned to favor the reaction with only the desired cysteine. Here we report on the design and biological characterization of covalent anilinoquinazolines as potent inhibitors of genetically engineered Aurora kinase in fission yeast.Keywords
This publication has 34 references indexed in Scilit:
- Chemical genetic strategy for targeting protein kinases based on covalent complementarityProceedings of the National Academy of Sciences, 2011
- The resurgence of covalent drugsNature Reviews Drug Discovery, 2011
- Proteus in the World of Proteins: Conformational Changes in Protein KinasesArchiv der Pharmazie, 2010
- Targeting cancer with small molecule kinase inhibitorsNature Reviews Cancer, 2009
- The Development of HKI‐272 and Related Compounds for the Treatment of CancerArchiv der Pharmazie, 2008
- Chemical Genetics: Where Genetics and Pharmacology MeetCell, 2007
- Drug–target residence time and its implications for lead optimizationNature Reviews Drug Discovery, 2006
- The Protein Kinase Complement of the Human GenomeScience, 2002
- Evolution of protein kinase signaling from yeast to manTrends in Biochemical Sciences, 2002
- Protein kinases — the major drug targets of the twenty-first century?Nature Reviews Drug Discovery, 2002